Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome

Perttu Lahtinen; Jonna Jalanka; Anna Hartikainen; Eero Mattila; Markku Hillilä; Jari Punkkinen; Jari Koskenpato; Veli-Jukka Anttila; Jyrki Tillonen; Reetta Satokari; Perttu Arkkila

doi:10.1111/apt.15740

Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome

Perttu Lahtinen, Jonna Jalanka, Anna Hartikainen, Eero Mattila, Markku Hillilä, Jari Punkkinen, Jari Koskenpato, Veli-Jukka Anttila, Jyrki Tillonen, Reetta Satokari, Perttu Arkkila

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Alimentary Pharmacology & Therapeutics
Volume	51
Issue number	12
Pages (from-to)	1321-1331
Number of pages	11
ISSN	0269-2813
DOIs	https://doi.org/10.1111/apt.15740
Publication status	Published - Jun 2020
MoE publication type	A1 Journal article-refereed

Fields of Science

3111 Biomedicine
3121 General medicine, internal medicine and other clinical medicine
ACTIVE ULCERATIVE-COLITIS
RECURRENT
EFFICACY
VALIDATION
REMISSION
BACTERIAL
SEVERITY
SYMPTOMS
ANXIETY
IBS
317 Pharmacy

Access to Document

10.1111/apt.15740

Randomised clinical trial AAMAccepted author manuscript, 119 KB

Cite this

Lahtinen, P., Jalanka, J., Hartikainen, A., Mattila, E., Hillilä, M., Punkkinen, J., Koskenpato, J., Anttila, V-J., Tillonen, J., Satokari, R., & Arkkila, P. (2020). Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 51(12), 1321-1331. https://doi.org/10.1111/apt.15740

@article{6e5e8f1bcec640af9dc2c6f3e82d9a01,

title = "Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome",

keywords = "3111 Biomedicine, 3121 General medicine, internal medicine and other clinical medicine, ACTIVE ULCERATIVE-COLITIS, RECURRENT, EFFICACY, VALIDATION, REMISSION, BACTERIAL, SEVERITY, SYMPTOMS, ANXIETY, IBS, 317 Pharmacy",

author = "Perttu Lahtinen and Jonna Jalanka and Anna Hartikainen and Eero Mattila and Markku Hillil{\"a} and Jari Punkkinen and Jari Koskenpato and Veli-Jukka Anttila and Jyrki Tillonen and Reetta Satokari and Perttu Arkkila",

year = "2020",

month = jun,

doi = "10.1111/apt.15740",

language = "English",

volume = "51",

pages = "1321--1331",

journal = "Alimentary Pharmacology & Therapeutics",

issn = "0269-2813",

publisher = "Wiley",

number = "12",

}

Lahtinen, P, Jalanka, J, Hartikainen, A , Mattila, E , Hillilä, M , Punkkinen, J , Koskenpato, J , Anttila, V-J , Tillonen, J , Satokari, R & Arkkila, P 2020, 'Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome', Alimentary Pharmacology & Therapeutics, vol. 51, no. 12, pp. 1321-1331. https://doi.org/10.1111/apt.15740

Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome. / Lahtinen, Perttu; Jalanka, Jonna; Hartikainen, Anna et al.

In: Alimentary Pharmacology & Therapeutics, Vol. 51, No. 12, 06.2020, p. 1321-1331.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome

AU - Lahtinen, Perttu

AU - Jalanka, Jonna

AU - Hartikainen, Anna

AU - Mattila, Eero

AU - Hillilä, Markku

AU - Punkkinen, Jari

AU - Koskenpato, Jari

AU - Anttila, Veli-Jukka

AU - Tillonen, Jyrki

AU - Satokari, Reetta

AU - Arkkila, Perttu

PY - 2020/6

Y1 - 2020/6

KW - 3111 Biomedicine

KW - 3121 General medicine, internal medicine and other clinical medicine

KW - ACTIVE ULCERATIVE-COLITIS

KW - RECURRENT

KW - EFFICACY

KW - VALIDATION

KW - REMISSION

KW - BACTERIAL

KW - SEVERITY

KW - SYMPTOMS

KW - ANXIETY

KW - IBS

KW - 317 Pharmacy

U2 - 10.1111/apt.15740

DO - 10.1111/apt.15740

M3 - Article

VL - 51

SP - 1321

EP - 1331

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

SN - 0269-2813

IS - 12

ER -